Home › Genetic Disorders › NCT02917460
Rady Children's Institute Genomic Biorepository
Genomic Biorepository: Protocol for the Collection, Storage, Analysis, and Distribution of Biological Samples, Genomic and Clinical Data
Who can join
All ages · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * All ages, races, genders, ethnicities, and health status will be eligible for participation. Enrollment will include that following vulnerable populations: pregnant women, neonates, fetuses, those with cognitive disabilities, pediatric patients, minorities, and employees. Exclusion Criteria: * None
About the study
Rady Children's Institute for Genomic Medicine (RCI) will collect biological samples (such as blood), derived genomic sequences (from DNA and RNA), and clinical features in a Biorepository as a standardized resource for future research studies. The purpose of the Genomic Institute Biorepository is to provide consented samples and data for basic and clinical research related to the genomic cause and treatment of childhood disease, and, in the future, as reference (Quality Control) data to improve the ability to make clinical diagnoses or clinical decisions.
In addition, the Biorepository will provide a mechanism for making a diagnosis of a genetic disease. That is, once genomic sequences have been derived from biological samples, they will be immediately analyzed. If a genetic disease is identified that appears to explain an affected child's clinical features, then those results will be confirmed by the medically accepted standard, and placed in the electronic health record.
What is being tested
- Genomic sequencing and molecular diagnostic results, if any (genetic)
Sponsor: Rady Pediatric Genomics & Systems Medicine Institute · Participants: 102,000 · Started: 2016-07
Contact the study team
- Dominic Baun, MBS · Phone: 858-576-1700
- Lauren Olsen, MSN · Phone: 858-576-1700
Official record on ClinicalTrials.gov — NCT02917460
Locations in the U.S.
| California | Rady Pediatric Genomics & Systems Medicine Institute, San Diego |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.